Health Tech Capitol | UW Health trial involves injecting stem cells into patients with heart failure
15848
post-template-default,single,single-post,postid-15848,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

UW Health trial involves injecting stem cells into patients with heart failure

24 May UW Health trial involves injecting stem cells into patients with heart failure

Posted at 16:04h in Uncategorized by
0 Likes

MADISON, Wis. – Doctors at UW Health are involved in a clinical trial using stem cells for the treatment of heart failure.

The CardiAMP therapy involves withdrawing a patient’s bone marrow. The bone marrow is then processed on-site to separate the stem cells from the plasma. The patient’s own stem cells are then injected into damaged areas of the heart using a catheter.

“It is hopeful that we can improve things.  I don’t think we can necessarily cure the damage, but I think we can improve things,” said Dr. Amish Raval, director of cardiovascular clinical research at UW Health.

The CardiAMP Heart Failure Trial is a phase III study that will eventually enroll up to 260 patients. For the first 10 patients, UW Health is one of three sites nationwide performing the procedure.

Read more at Channel 3000

No Comments

Sorry, the comment form is closed at this time.